West Pharmaceutical Services Total Current Liabilities 2010-2024 | WST

West Pharmaceutical Services total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • West Pharmaceutical Services total current liabilities for the quarter ending September 30, 2024 were $0.517B, a 3.19% decline year-over-year.
  • West Pharmaceutical Services total current liabilities for 2023 were $0.672B, a 29.44% increase from 2022.
  • West Pharmaceutical Services total current liabilities for 2022 were $0.519B, a 12.64% decline from 2021.
  • West Pharmaceutical Services total current liabilities for 2021 were $0.594B, a 18.02% increase from 2020.
West Pharmaceutical Services Annual Total Current Liabilities
(Millions of US $)
2023 $672
2022 $519
2021 $594
2020 $503
2019 $342
2018 $284
2017 $280
2016 $241
2015 $314
2014 $253
2013 $237
2012 $262
2011 $243
2010 $170
2009 $171
West Pharmaceutical Services Quarterly Total Current Liabilities
(Millions of US $)
2024-09-30 $517
2024-06-30 $634
2024-03-31 $648
2023-12-31 $672
2023-09-30 $534
2023-06-30 $512
2023-03-31 $535
2022-12-31 $519
2022-09-30 $457
2022-06-30 $565
2022-03-31 $585
2021-12-31 $594
2021-09-30 $559
2021-06-30 $473
2021-03-31 $483
2020-12-31 $503
2020-09-30 $448
2020-06-30 $375
2020-03-31 $344
2019-12-31 $342
2019-09-30 $335
2019-06-30 $313
2019-03-31 $301
2018-12-31 $284
2018-09-30 $289
2018-06-30 $288
2018-03-31 $263
2017-12-31 $280
2017-09-30 $300
2017-06-30 $289
2017-03-31 $257
2016-12-31 $241
2016-09-30 $237
2016-06-30 $239
2016-03-31 $241
2015-12-31 $314
2015-09-30 $300
2015-06-30 $314
2015-03-31 $297
2014-12-31 $253
2014-09-30 $243
2014-06-30 $221
2014-03-31 $228
2013-12-31 $237
2013-09-30 $247
2013-06-30 $219
2013-03-31 $208
2012-12-31 $262
2012-09-30 $276
2012-06-30 $320
2012-03-31 $302
2011-12-31 $243
2011-09-30 $229
2011-06-30 $193
2011-03-31 $183
2010-12-31 $170
2010-09-30 $158
2010-06-30 $159
2010-03-31 $184
2009-12-31 $171
2009-09-30 $163
2009-06-30 $162
2009-03-31 $139
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.239B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
Labcorp (LH) United States $20.088B 16.66
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49